The typical class side effects of Trk inhibitors are weight gain, observed in 53% of treated patients; dizziness, which may or may not be associated with ataxia, in 41%; and pain after discontinuing the Trk inhibitor, in 35% of patients. This evidence concerns the gene NTRK1 and Ataxia.